Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Barbour

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2018
Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized TrialSandra A Springer, Angela Di Paola, Marwan M Azar, et al.
Plos One|March 14, 2012
Survival from XDR-TB is associated with modifiable clinical characteristics in rural South AfricaSheela V Shenoi, Ralph P Brooks, Russell Barbour, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2018
Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized TrialSandra A Springer, Angela Di Paola, Marwan M Azar, et al.
Plos One|March 14, 2012
Survival from XDR-TB is associated with modifiable clinical characteristics in rural South AfricaSheela V Shenoi, Ralph P Brooks, Russell Barbour, et al.
Pageof 4